Legal Disclaimer
This website is owned and operated by XPhyto Therapeutics Corp. (“XPhyto” or the “Company”). By using this website, you agree to the following terms and conditions.
Copyright
All materials (graphics, icons, HTML, javascripts, color schemes, multimedia, logos, photographs, copywriting, et al) that appear on this website are the property of XPhyto. Unless otherwise specified, no user has permission to copy, redistribute, reproduce, or republish, in any form, any information found in the pages of this website. Any user who, without authorization, re-transmits, copies or modifies any trademarks may violate federal or common law trademark and/or copywriter law, and may be subject to legal action.
Other materials on this website not originally produced by XPhyto (some audio, video, trademarks, et al.) are copyrighted by their respective creators/owners and appear here either by permission, example, or as public domain reference material.
Cautionary Note Regarding Forward-Looking Statements
This website contains forward-looking statements and information within the meaning of applicable securities laws. Such statements reflect the current expectations and assumptions of BioNxt Solutions Inc. (“BioNxt”) regarding future events, including the development and commercialization of its innovative drug delivery technologies, anticipated business strategies, regulatory approval processes, market conditions, and industry trends. Forward-looking statements are often identified by words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “potential,” “should,” “will,” or similar expressions indicating future possibilities.
Risks and Uncertainties
These forward-looking statements are based on various assumptions that are subject to numerous known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied by such statements. Key factors that may impact BioNxt’s performance include, but are not limited to:
• Scientific, technical, or clinical challenges associated with developing and testing new drug delivery technologies
• The ability to secure regulatory approvals in a timely manner
• Changes in global market demand for therapies in BioNxt’s target areas, including neurodegenerative and autoimmune diseases
• Competitive pressures from other biotechnology and pharmaceutical companies
• Dependence on strategic partnerships and research collaborations
• Availability of financial resources to fund ongoing and future projects
• Changes in laws, regulations, or policies affecting the healthcare and pharmaceutical industries
• Potential intellectual property or patent-related disputes
BioNxt undertakes no obligation to update forward-looking statements or revise them to reflect new events or circumstances, except as required by law.
Limitations of Forward-Looking Statements
Forward-looking statements are provided for the purpose of conveying management’s expectations for the future and should not be relied upon as guarantees of future performance. Actual results could vary significantly due to a wide range of factors, many of which are beyond BioNxt’s control. Potential investors and stakeholders are encouraged to consult BioNxt’s filings with the relevant securities regulatory authorities for a detailed discussion of these risks and uncertainties.
By accessing this website, you acknowledge and agree that BioNxt Solutions Inc. is not liable for any loss or damage arising from the use of forward-looking information contained herein.
For further details or inquiries, please contact BioNxt Investor Relations.
Invest in Bionxt, invest in innovation
Learn more about Bionxt’s innovation to impact strategy and get access to Bionxt investor information.
CSE:BNXT FSE:BXT OTCQB:BNXTF